| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/20/2011 | WO2010032006A3 Treatment of adrenal insufficiency |
| 01/20/2011 | WO2010017325A3 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy |
| 01/20/2011 | WO2010007441A3 Phosphopeptides and use of the same |
| 01/20/2011 | WO2009150630A3 Compositions of carbon dioxide adduct of ertapenem and polymorphic forms of ertapenem monosodium salt |
| 01/20/2011 | WO2009120889A3 Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists |
| 01/20/2011 | WO2009099830A3 Edible film-strips for immediate release of active ingredients |
| 01/20/2011 | WO2009004595A3 Enhancement of the efficacy of therapeutic proteins |
| 01/20/2011 | US20110015216 Solid Pharmaceutical Dosage Form |
| 01/20/2011 | US20110015145 Cladribine formulations for improved oral and transmucosal delivery |
| 01/20/2011 | US20110014299 Solid preparation comprising alogliptin and metformin hydrochloride |
| 01/20/2011 | US20110014298 Discontinuous Surface Coating for Particles |
| 01/20/2011 | US20110014297 Multimodal therapeutic hybrid particle complex and system |
| 01/20/2011 | US20110014296 Drug Delivery Nanodevice, its Preparation Method and Uses Thereof |
| 01/20/2011 | US20110014295 Method of determining the weight of the coating to be applied to form a controlled release dosage form |
| 01/20/2011 | US20110014294 Stimulation of ocular retrobulbar blood flow using ocular irritants |
| 01/20/2011 | US20110014293 Cleavage kit, and gene therapy by using the same and nucleic acid cleavage detection apparatus |
| 01/20/2011 | US20110014292 method of prophylaxis and agents for use therein |
| 01/20/2011 | US20110014291 Novel Polymorphs of Bosentan |
| 01/20/2011 | US20110014290 System and method for facilitating hemostasis with an absorbable sponge |
| 01/20/2011 | US20110014289 Reticulated Elastomeric Matrices, Their Manufacture and Use in Implantable Devices |
| 01/20/2011 | US20110014288 Microcapsules comprising a fat-soluble active substance |
| 01/20/2011 | US20110014287 Silk Fibroin Hydrogels and Uses Thereof |
| 01/20/2011 | US20110014286 Mixture for producing rapidly disintegrating tablets |
| 01/20/2011 | US20110014285 N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen |
| 01/20/2011 | US20110014284 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 01/20/2011 | US20110014283 Novel dosage form |
| 01/20/2011 | US20110014282 Pharmaceutical composition for poorly soluble drugs |
| 01/20/2011 | US20110014281 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 01/20/2011 | US20110014280 Sequestering subunit and related compositions and methods |
| 01/20/2011 | US20110014279 Bioactive complex compositions and methods of use thereof |
| 01/20/2011 | US20110014278 Compositions Comprising Dehydrated Micro-Organisms, Method for Preparing Same, and Uses Thereof |
| 01/20/2011 | US20110014277 Smoking Cessation With Body Weight Maintenance And Nutritional Supplement |
| 01/20/2011 | US20110014276 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |
| 01/20/2011 | US20110014275 Compositions and methods for inhibiting or inducing adipogenesis |
| 01/20/2011 | US20110014274 Vaccine composition containing synthetic adjuvant |
| 01/20/2011 | US20110014273 Method of Treating BCC |
| 01/20/2011 | US20110014272 Method for adjuvanting lipopolysaccharide (LPS) of Gram-negative bacteria |
| 01/20/2011 | US20110014271 Substituted Aniline Derivatives |
| 01/20/2011 | US20110014270 Prevention and treatment of ischemia-reperfusion injury and related conditions |
| 01/20/2011 | US20110014269 Civamide patch for localized post-incisional neuropathic pain |
| 01/20/2011 | US20110014268 Formulation for oral administration |
| 01/20/2011 | US20110014267 Biosynthetic cartilaginous matrix and methods for their production |
| 01/20/2011 | US20110014266 Expandable, porous apatite/collagen composite, and its production method |
| 01/20/2011 | US20110014260 System and method for liver cell culture and maturation |
| 01/20/2011 | US20110014259 Alpha adrenergic receptor agonists for prevention or treatment of a hematoma, edema, and/or deep vein thrombosis |
| 01/20/2011 | US20110014251 Microvesicles |
| 01/20/2011 | US20110014250 Inhibitors of 15-hydroxyprostaglandin dehydrogenase for stimulating pigmentation of the skin or skin appendages |
| 01/20/2011 | US20110014248 Cosmetic use of microorganism(s) for the treatment of scalp disorders |
| 01/20/2011 | US20110014247 Methods and compositions for oral administration of proteins |
| 01/20/2011 | US20110014246 Amorphous arformoterol l-(+)-tartrate |
| 01/20/2011 | US20110014245 Therapeutic method of administering pharmaceutical titanium dioxide composite and light irradiation |
| 01/20/2011 | US20110014244 Inorganic Shaped Bodies And Methods For Their Production And Use |
| 01/20/2011 | US20110014243 Pharmaceutical compositions |
| 01/20/2011 | US20110014135 Vitamin formulation |
| 01/20/2011 | US20110014134 Suspension aerosol formulations of pharmaceutical products |
| 01/20/2011 | US20110014133 Compositions and Methods to Treat Asthma |
| 01/20/2011 | US20110014132 Solid effervescent mixture for the oral absorption |
| 01/20/2011 | US20110014131 Nanomolding micron and nano scale features |
| 01/20/2011 | US20110014130 Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing |
| 01/20/2011 | US20110014124 Targeted atherosclerosis treatment |
| 01/20/2011 | US20110014123 RNA interference mediating small RNA molecules |
| 01/20/2011 | US20110014118 Nanotherapeutic colloidal metal compositions and methods |
| 01/20/2011 | US20110014117 Anti-igf1r |
| 01/20/2011 | US20110012276 Method For Manufacturing Molded Article With Core |
| 01/20/2011 | US20110011961 Granules comprising a beta-lactam antibiotic |
| 01/20/2011 | US20110011959 Particle Size Reduction Apparatus, and Use Thereof |
| 01/20/2011 | US20110010817 Articles of Manufacture Releasing an Active Ingredient |
| 01/20/2011 | DE102010024692A1 Packaging unit comprises identical or different water-soluble effervescent tablets comprising drug and/or dietary supplement, where the total contents of the packaging unit for a single intake is determined by the user |
| 01/20/2011 | DE102009033621A1 Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen Separating layers for pharmaceutical preparations for prevention of interactions between drugs and pharmaceutically-technological auxiliaries |
| 01/20/2011 | CA2768452A1 Material and process for incorporation of low dosage active pharmaceutical ingredients and use thereof |
| 01/20/2011 | CA2768444A1 Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines |
| 01/20/2011 | CA2768383A1 Pellets formulation |
| 01/20/2011 | CA2768275A1 Improvements in and relating to colon cleansing compositions |
| 01/20/2011 | CA2768242A1 Porous-wall hollow glass microspheres as carriers for biomolecules |
| 01/20/2011 | CA2768237A1 Treatment method |
| 01/20/2011 | CA2768018A1 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 01/20/2011 | CA2768006A1 Olopatadine nasal spray regimen for children |
| 01/20/2011 | CA2767973A1 Sustained-release drug carrier composition |
| 01/20/2011 | CA2767971A1 Treating patients with intravenous ibuprofen |
| 01/20/2011 | CA2767833A1 N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen |
| 01/20/2011 | CA2767614A1 Fusidic acid dosing regimens for treatment of bacterial infections |
| 01/20/2011 | CA2765220A1 Methods for inhibiting yellow color and peroxide formation in a composition |
| 01/20/2011 | CA2738151A1 Eye drop with difluprednate for macular edema treatment |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275479A1 Pharmaceutical metered dose inhaler and methods relating thereto |
| 01/19/2011 | EP2275426A1 Metallo-organic system for the encapsulation and release of compounds of interest, method for obtaining same and uses thereof |
| 01/19/2011 | EP2275202A1 Carbonyl compound remover |
| 01/19/2011 | EP2275152A1 Calcium-containing structures and methods of making and using the same |
| 01/19/2011 | EP2275141A1 Tastemasked pharmaceutical compositions |
| 01/19/2011 | EP2275139A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID |
| 01/19/2011 | EP2275133A1 Use of bioadhesives and adjuvants for the mucosal delivery of antigens |
| 01/19/2011 | EP2275109A2 Pregnane steroids for use in the treatment of CNS disorders |
| 01/19/2011 | EP2275099A1 Treatment of faecal incontinence with 1r,2s-methoxamine |
| 01/19/2011 | EP2275098A1 Novel oral formulations of ospemifene |
| 01/19/2011 | EP2275094A2 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
| 01/19/2011 | EP2275093A2 Pharmaceutical formulation |
| 01/19/2011 | EP2275092A1 Taxane pharmaceutical formulation |
| 01/19/2011 | EP2275091A1 Pharmaceutical compositions comprising adsorbates of an amorphous drug |
| 01/19/2011 | EP2275090A2 Microparticles prepared using an ionic liquid |
| 01/19/2011 | EP2275089A1 Preparation of biodegradable microparticles containing a biologically active agent |